Story excerpt provided by Cincinnati Business Courier.
Written by Steve Watkins.
Cincinnati startup drug developer Aerpio Pharmaceuticals Inc. is making its stock available to the public for the first time.
Blue Ash-based Aerpio paved the way to enter the public stock market in March when it completed what’s known as a reverse merger. That’s a process in which it merged with a publicly traded shell company without any operations. The company then changed names to Aerpio and elected a new board of Aerpio leaders. The reverse merger was accompanied by a private placement stock sale raising $40 million.
Click here to read the complete article.
Originally published June 28, 2017.